CareMax Statistics
Total Valuation
CareMax has a market cap or net worth of 4. The enterprise value is 496.78 million.
| Market Cap | 4 |
| Enterprise Value | 496.78M |
Important Dates
The next estimated earnings date is Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CareMax has 3.81 million shares outstanding. The number of shares has increased by 9.83% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.81M |
| Shares Change (YoY) | +9.83% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 24.72% |
| Owned by Institutions (%) | 7.64% |
| Float | 2.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.63 |
| EV / Sales | 0.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.02 |
Financial Position
The company has a current ratio of 0.23
| Current Ratio | 0.23 |
| Quick Ratio | 0.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.29 |
| Interest Coverage | -1.92 |
Financial Efficiency
Return on equity (ROE) is -328.42% and return on invested capital (ROIC) is -11.76%.
| Return on Equity (ROE) | -328.42% |
| Return on Assets (ROA) | -10.59% |
| Return on Invested Capital (ROIC) | -11.76% |
| Return on Capital Employed (ROCE) | 179.73% |
| Revenue Per Employee | 541,070 |
| Profits Per Employee | -539,901 |
| Employee Count | 1,450 |
| Asset Turnover | 0.98 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -100.00% in the last 52 weeks. The beta is 0.55, so CareMax's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -100.00% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 2.15 |
| Relative Strength Index (RSI) | 23.49 |
| Average Volume (20 Days) | 54,072 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, CareMax had revenue of 784.55 million and -782.86 million in losses. Loss per share was -207.89.
| Revenue | 784.55M |
| Gross Profit | -25.95M |
| Operating Income | -135.93M |
| Pretax Income | -783.72M |
| Net Income | -782.86M |
| EBITDA | -108.33M |
| EBIT | -135.93M |
| Loss Per Share | -207.89 |
Balance Sheet
The company has 16.43 million in cash and 513.21 million in debt, giving a net cash position of -496.78 million or -130.22 per share.
| Cash & Cash Equivalents | 16.43M |
| Total Debt | 513.21M |
| Net Cash | -496.78M |
| Net Cash Per Share | -130.22 |
| Equity (Book Value) | -147.76M |
| Book Value Per Share | -38.73 |
| Working Capital | -406.21M |
Cash Flow
In the last 12 months, operating cash flow was -51.76 million and capital expenditures -10.17 million, giving a free cash flow of -61.94 million.
| Operating Cash Flow | -51.76M |
| Capital Expenditures | -10.17M |
| Free Cash Flow | -61.94M |
| FCF Per Share | -16.23 |
Margins
Gross margin is -3.31%, with operating and profit margins of -17.33% and -99.78%.
| Gross Margin | -3.31% |
| Operating Margin | -17.33% |
| Pretax Margin | -99.89% |
| Profit Margin | -99.78% |
| EBITDA Margin | -13.81% |
| EBIT Margin | -17.33% |
| FCF Margin | n/a |
Dividends & Yields
CareMax does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.83% |
| Shareholder Yield | -9.83% |
| Earnings Yield | -19,571,400,000.00% |
| FCF Yield | -1,548,375,000.00% |
Stock Splits
The last stock split was on February 1, 2024. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Feb 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
CareMax has an Altman Z-Score of -3.1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.1 |
| Piotroski F-Score | n/a |